Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma

Hamda Memon,1 Ricardo Parrondo,2 Julianna Schreurs,2 Ernesto Ayala,2 Madiha Iqbal2 1Department of Family Medicine, Geisinger Health in Wilkes Barre, Wilkes Barre, Pennsylvania, USA; 2Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USACorrespondence: Madiha Iqbal, Department...

Full description

Saved in:
Bibliographic Details
Main Authors: Memon H, Parrondo R, Schreurs J, Ayala E, Iqbal M
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:Journal of Blood Medicine
Subjects:
Online Access:https://www.dovepress.com/autologous-hematopoietic-cell-transplant-as-an-effective-treatment-mod-peer-reviewed-fulltext-article-JBM
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555951765684224
author Memon H
Parrondo R
Schreurs J
Ayala E
Iqbal M
author_facet Memon H
Parrondo R
Schreurs J
Ayala E
Iqbal M
author_sort Memon H
collection DOAJ
description Hamda Memon,1 Ricardo Parrondo,2 Julianna Schreurs,2 Ernesto Ayala,2 Madiha Iqbal2 1Department of Family Medicine, Geisinger Health in Wilkes Barre, Wilkes Barre, Pennsylvania, USA; 2Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USACorrespondence: Madiha Iqbal, Department of Medicine,Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, 4500 San Pablo road, Jacksonville, FL, 32224, USA, Email Iqbal.madiha@mayo.eduAbstract: Systemic sclerosis (SSc) is a multi-system disease characterized by a dysregulated immune system. Autologous hematopoietic cell transplantation (AHCT) is the only treatment that has been shown to confer significant benefit in controlling disease and improving survival for patients with SSc. A diagnosis of multiple myeloma (MM) after the diagnosis of SSc is rare and optimal treatment in such cases remains unclear. We here report a case of a female patient who was diagnosed with MM while she was undergoing evaluation for AHCT due to SSc. A novel conditioning regimen for AHCT, with therapeutic efficacy in SSc and MM was offered to the patient, resulting in long term remission of both diseases.Keywords: systemic sclerosis, autologous hematopoietic cell transplantation, multiple myeloma
format Article
id doaj-art-138781cc43034856b00ac7e7033c5ff2
institution Kabale University
issn 1179-2736
language English
publishDate 2025-01-01
publisher Dove Medical Press
record_format Article
series Journal of Blood Medicine
spelling doaj-art-138781cc43034856b00ac7e7033c5ff22025-01-07T16:42:40ZengDove Medical PressJournal of Blood Medicine1179-27362025-01-01Volume 1671398973Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple MyelomaMemon HParrondo RSchreurs JAyala EIqbal MHamda Memon,1 Ricardo Parrondo,2 Julianna Schreurs,2 Ernesto Ayala,2 Madiha Iqbal2 1Department of Family Medicine, Geisinger Health in Wilkes Barre, Wilkes Barre, Pennsylvania, USA; 2Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USACorrespondence: Madiha Iqbal, Department of Medicine,Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, 4500 San Pablo road, Jacksonville, FL, 32224, USA, Email Iqbal.madiha@mayo.eduAbstract: Systemic sclerosis (SSc) is a multi-system disease characterized by a dysregulated immune system. Autologous hematopoietic cell transplantation (AHCT) is the only treatment that has been shown to confer significant benefit in controlling disease and improving survival for patients with SSc. A diagnosis of multiple myeloma (MM) after the diagnosis of SSc is rare and optimal treatment in such cases remains unclear. We here report a case of a female patient who was diagnosed with MM while she was undergoing evaluation for AHCT due to SSc. A novel conditioning regimen for AHCT, with therapeutic efficacy in SSc and MM was offered to the patient, resulting in long term remission of both diseases.Keywords: systemic sclerosis, autologous hematopoietic cell transplantation, multiple myelomahttps://www.dovepress.com/autologous-hematopoietic-cell-transplant-as-an-effective-treatment-mod-peer-reviewed-fulltext-article-JBMsystemic sclerosisautologous hematopoietic cell transplantationmultiple myeloma
spellingShingle Memon H
Parrondo R
Schreurs J
Ayala E
Iqbal M
Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
Journal of Blood Medicine
systemic sclerosis
autologous hematopoietic cell transplantation
multiple myeloma
title Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
title_full Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
title_fullStr Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
title_full_unstemmed Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
title_short Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
title_sort autologous hematopoietic cell transplant as an effective treatment modality for systemic sclerosis and multiple myeloma
topic systemic sclerosis
autologous hematopoietic cell transplantation
multiple myeloma
url https://www.dovepress.com/autologous-hematopoietic-cell-transplant-as-an-effective-treatment-mod-peer-reviewed-fulltext-article-JBM
work_keys_str_mv AT memonh autologoushematopoieticcelltransplantasaneffectivetreatmentmodalityforsystemicsclerosisandmultiplemyeloma
AT parrondor autologoushematopoieticcelltransplantasaneffectivetreatmentmodalityforsystemicsclerosisandmultiplemyeloma
AT schreursj autologoushematopoieticcelltransplantasaneffectivetreatmentmodalityforsystemicsclerosisandmultiplemyeloma
AT ayalae autologoushematopoieticcelltransplantasaneffectivetreatmentmodalityforsystemicsclerosisandmultiplemyeloma
AT iqbalm autologoushematopoieticcelltransplantasaneffectivetreatmentmodalityforsystemicsclerosisandmultiplemyeloma